title: [Acromegalic myocardiopathy].
abstract: Acromegaly is characterized by chronic growth hormone hypersecretion. Cardiovascular alterations such as hypertension, left ventricular hypertrophy, cardiac rhythm disturbances and valvular disease are common in this disease and are the main cause of death. Control of acromegaly by surgery or pharmacotherapy has been shown to improve cardiovascular morbidity. We report a case of acromegalic myocardiopathy in a 59-year-old woman with dilated myocardiopathy who presented ventricular diameter and contractility normalization following medical treatment.
authors.affiliation: Servicio de Endocrinología y Nutrición, Hospital Universitario Puerta de Hierro, Madrid, Spain. davidclemente@aol.es
authors.forename: David
authors.initials: D
authors.lastname: Clemente Gallego
authors.forename: Manuel
authors.initials: M
authors.lastname: Gómez Bueno
authors.forename: Tomás
authors.initials: T
authors.lastname: Lucas Morante
mesh_terms: D000172:Acromegaly / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D000236:Adenoma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D002311:Cardiomyopathy, Dilated / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D002349:Carpal Tunnel Syndrome / Q000150:complications; D005260:Female; D006349:Heart Valve Diseases / Q000150:complications; D006801:Humans; D008875:Middle Aged; D010456:Peptides, Cyclic / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D012074:Remission Induction; D012891:Sleep Apnea Syndromes / Q000150:complications; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D010456:Peptides, Cyclic; C060347:lanreotide; D013004:Somatostatin